Disease/Infection News

RSS

Whole genome sequencing shows tight clustering between bacterial isolates in returning travelers

Thirteen patients with OXA-48-producing Klebsiella pneumoniae ST392 have been reported by Sweden and Norway between January and April 2018 - all returning travellers with prior hospital admission in Gran Canaria, Spain.

13 Jul 2018

New study finds ticks that can carry Lyme and other tick-borne diseases

The results of a nationwide citizen scientist study, sponsored by the Bay Area Lyme Foundation and conducted by Northern Arizona University and Colorado State University, found ticks capable of carrying Lyme and other tick-borne diseases in 83 counties throughout the country where they had not previously been recorded

13 Jul 2018

Imaging techniques may help assess immune system recovery in HIV patients

Findings from an animal study suggest that a non-invasive imaging technique could, with further development, become a useful tool to assess immune system recovery in people receiving treatment for HIV infection.

13 Jul 2018

Researchers decipher key component behind rising epidemic of pathogens in West Africa

A research team from several institutions being led by the University of California San Diego has deciphered a key component behind a rising epidemic of pathogens that the World Health Organization (WHO) recently added to its list of critical emerging diseases.

13 Jul 2018

Georgia State professor receives federal grant to study virus similar to Ebola virus

Dr. Christopher Basler, a professor in the Institute for Biomedical Sciences at Georgia State University, director of the university's Center for Microbial Pathogenesis and a Georgia Research Alliance Eminent Scholar in Microbial Pathogenesis, has received a two-year, $419,100 federal grant to study a virus similar to Ebola virus that causes disease in animals but not in humans.

12 Jul 2018

Aeras announces publication of Phase 2 results of two TB vaccines

Aeras, a nonprofit organization dedicated to developing vaccines against tuberculosis (TB), today announced the publication of the full results from a Phase 2, randomized, controlled clinical trial of two TB vaccines-- the currently available BCG vaccine and an investigational vaccine, H4:IC31--in the New England Journal of Medicine (NEJM).

12 Jul 2018

Fighting cancer with engineered cancer cells

Researchers at Brigham and Women's Hospital have engineered cancer cells that track and kill cancer cells. The modified cancer cells have demonstrated anti-cancer efficacy in preclinical studies, destroying both primary and metastatic tumours.

12 Jul 2018

Associate professor receives $1 million grant for disease research

Associate Professor Janelle Ayres is the recipient of a $1 million grant from the W. M. Keck Foundation to study new ways to treat deadly infections including sepsis and the flu, both of which require novel therapies beyond antibiotics and antivirals to effectively combat.

12 Jul 2018

Study: Hepatitis C vaccine could drastically reduce transmission among injecting drug users

Among the most serious consequences of the opioid epidemic is the spread of hepatitis C among injecting drug users.

12 Jul 2018

New 3D model of 1918 H1 pandemic influenza virus could benefit VLP vaccine projects

Virus-like particles are protein-based structures that mimic viruses and bind to antibodies. Because VLPs are not infectious, they show considerable promise as vaccine platforms for many viral diseases, including influenza.

12 Jul 2018

Molecular insights of NagA enzyme could help combat TB

Research by a team led by Dr Elizabeth Fullam, has revealed new findings about an enzyme found in Mycobacterium tuberculosis the bacterium that causes TB.

12 Jul 2018

New class of chemical compounds has potential for treating Zika virus and RSV

A new and promising class of chemical compounds has major potential for treating Zika virus and respiratory syncytial virus, or RSV, according to a new study by University of Alberta scientists. The next step is to develop a drug.

12 Jul 2018

UM researchers awarded NIH funding to study bacterium that causes Lyme disease

University of Montana researchers Dan Drecktrah and Scott Samuels were recently awarded $449,998 from the National Institutes of Health for the first year of a five-year project to study the bacterium that causes Lyme disease.

11 Jul 2018

Study identifies cost-effective strategy to treat nail fungus using nanotechnology

Onychomycosis, a nail fungus that causes nail disfigurement, pain, and increased risk of soft tissue infection, impacts millions of people worldwide. There are several topical antifungal treatments currently available; however, treatment failure remains high due to a number of factors.

11 Jul 2018

Scientists elucidate how E.coli bacteria attach to host intestinal epithelium

Osaka University-led researchers clarified how pathogenic E. coli bacteria attached to the host intestinal epithelium.

11 Jul 2018

Differences in mouth bacteria of HIV-infected youth may increase risk of cavities

A team of scientists from The Forsyth Institute, a global leader in oral health research, in collaboration with the NIH-funded Pediatric HIV/AIDS Cohort Study, has published the results of a new study indicating that differences in the mouth bacteria of youth born with HIV may increase their risk of cavities.

11 Jul 2018